PFE Jun 2024 45.000 put
| Previous Close | 15.45 |
| Open | 15.55 |
| Bid | 16.15 |
| Ask | 16.70 |
| Strike | 45.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 15.45 - 15.55 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 387 |
Yahoo FinanceNovo Nordisk is the 2023 Yahoo Finance Company of the Year
Novo Nordisk was the talk of the pharma and medical world this year — and also the world of People magazine and E! with stars from Amy Schumer to Elon Musk using the firm’s diabetes and weight-loss medicines, Ozempic and Wegovy. This is partly why Novo Nordisk is Yahoo Finance's 2023 Company of the Year.
Insider Monkey12 Healthcare Stocks Billionaires Like the Most
In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, […]
Business WireMarstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B
NEW YORK, December 10, 2023--Pfizer Inc. (NYSE: PFE) today presented results from the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab for the treatment of people with severe hemophilia A and moderately severe to severe hemophilia B without inhibitors to Factor VIII (FVIII) or Factor IX (FIX). The results from the BASIS trial demonstrated a statistically significant and clinically meaningful effect on annualized bleeding rate (ABR). The findings were presented today at t
